What Medicare Beneficiaries Should Know About Recent CMS Announcements

Medicare keeps changing.

Unfortunately, CMS announcements are rarely written in plain English.

They arrive filled with phrases such as “rate announcements,” “risk-adjustment updates,” “program instructions,” and “contract-year technical changes.” By the time most people reach the third paragraph, they may feel as though they accidentally wandered into a meeting of government accountants.

But several recent announcements from the Centers for Medicare & Medicaid Services could eventually affect what beneficiaries pay, which benefits plans offer, how prescription drugs are covered, and how Medicare Advantage and Part D plans operate.

Some changes are already in effect for 2026. Others will influence coverage beginning in 2027.

Here is what Medicare beneficiaries need to know—and what they should not assume.

First, What Does CMS Actually Do?

CMS is the federal agency that administers Medicare and sets many of the rules governing Medicare Advantage, Medicare Part D, Original Medicare payments, and other federal healthcare programs.

CMS does not personally design every Medicare Advantage or prescription drug plan. Private insurance companies make many plan-level decisions, subject to federal requirements.

That distinction matters.

When CMS announces that payments to Medicare Advantage plans will increase, it does not mean every beneficiary will receive a larger dental allowance, a lower premium, or a check in the mail.

It means the financial and regulatory environment surrounding the plans is changing.

Insurance companies will then decide how to structure their individual plans within those rules.

Medicare Advantage Payments Are Scheduled to Increase for 2027

CMS finalized its 2027 Medicare Advantage and Part D Rate Announcement on April 6, 2026.

The agency estimates that its finalized payment policies will produce a net average increase of 2.48%, representing more than $13 billion in additional Medicare Advantage payments for 2027. (CMS)

That sounds like good news for beneficiaries.

It could be—but it is not a guarantee.

Higher overall payments may help plans maintain benefits, manage rising medical costs, expand certain services, or compete through lower premiums and additional benefits. However, each insurance company still decides how to use its available funding.

A plan could:

• Maintain its current benefits
• Add or increase supplemental benefits
• Reduce certain copayments
• Raise other copayments
• Change its provider network
• Change its prescription formulary
• Introduce a premium
• Leave a county or service area

The national average does not tell you what will happen to the particular plan offered in your ZIP code.

That is why beneficiaries should review their individual Annual Notice of Change rather than relying on headlines about Medicare funding.

To understand why location matters so much, read What Medicare Plans Are Available in My Area?.

The 2027 Medicare Advantage and Part D Rules Are Being Simplified

CMS also finalized policy changes for Medicare Advantage and Part D beginning in 2027.

The agency says the changes are intended to simplify plan choices, reduce administrative burden, strengthen program accountability, and focus quality measurements more heavily on clinical care, outcomes, and meaningful differences among plans. (CMS)

One area receiving attention is the Medicare Star Ratings system.

Medicare uses a five-star system to help consumers compare the quality and performance of Medicare Advantage and Part D contracts. Ratings may consider areas such as customer service, preventive care, medication management, complaints, health outcomes, and members’ experiences.

CMS is adjusting the measures used in that system so the ratings concentrate more heavily on differences the agency considers meaningful.

That could make the ratings easier to understand over time.

However, beneficiaries should not choose a plan based entirely on the number of stars.

A highly rated plan may still exclude your physician, charge more for one of your medications, or have a hospital network that does not meet your needs.

Star Ratings can be useful, but they are only one part of the decision.

Your doctors, prescriptions, pharmacies, expected medical use, premiums, copayments, maximum out-of-pocket limit, and travel needs may be far more important.

Our guide to the three most important questions to ask about Medicare explains how to examine the practical details rather than relying on advertising.

The Part D Coverage Gap Is Gone

The old Medicare Part D coverage gap—commonly called the “donut hole”—has been removed under the redesigned Part D benefit.

CMS is now codifying the redesigned structure for 2027 and future years. The agency’s final rule continues provisions that eliminate the coverage-gap phase, reduce the annual out-of-pocket threshold, remove cost sharing in the catastrophic phase, and establish the new manufacturer discount structure.

For 2026, the maximum annual deductible allowed under the standard Part D benefit is $615.

After the deductible, the standard benefit generally has beneficiaries paying 25% of covered drug costs during the initial coverage phase until they reach the annual out-of-pocket limit. The precise amount a person pays still depends on the plan, the medication’s tier, negotiated prices, pharmacy status, and coverage rules.

The annual out-of-pocket cap for covered Part D drugs is $2,100 in 2026.

That cap is a major protection, but several cautions are important:

First, it applies to covered Part D drugs.

If a medication is excluded from your plan’s formulary, the full amount you pay may not count toward the cap.

Second, the cap does not mean your medications will cost $2,100.

Many beneficiaries will spend much less.

Third, premiums are separate.

The monthly Part D or Medicare Advantage plan premium generally does not count toward the prescription-drug out-of-pocket cap.

To compare formularies, pharmacies, deductibles, and estimated annual costs, see How SunFire Matrix Helps You Compare Medicare Plans for Free.

The Medicare Prescription Payment Plan Continues

People with Medicare drug coverage can use the Medicare Prescription Payment Plan to spread eligible out-of-pocket prescription expenses across monthly payments instead of paying the entire amount at the pharmacy counter.

CMS has incorporated the program into its Medicare Advantage and Part D rules.

This can be helpful when a beneficiary faces a large prescription cost early in the year.

Suppose your medication requires a substantial payment in January. Under the payment plan, that expense may be divided across the remaining months of the calendar year.

But this point cannot be emphasized enough:

The Medicare Prescription Payment Plan is a payment option—not a discount.

It does not reduce the negotiated cost of the drug.

It does not automatically lower your annual spending.

It changes when you pay.

The program may be helpful for cash flow, especially for people who take expensive medications. However, someone who joins later in the year will have fewer months over which to divide the remaining balance, which can mean larger monthly bills.

Beneficiaries should contact their Medicare drug plan for details and should ask how their anticipated costs would be divided before enrolling.

CMS Has Launched a $50 Medicare GLP-1 Bridge Program

One of CMS’s most closely watched recent announcements involves certain GLP-1 medications.

CMS announced that beginning July 1, 2026, some Medicare beneficiaries with Part D coverage may be eligible to receive certain GLP-1 medications for $50 per monthly supply through the Medicare GLP-1 Bridge.

These medications may be prescribed for conditions such as obesity, diabetes, cardiovascular risk reduction, or obstructive sleep apnea, depending on the specific medication’s FDA-approved indication and the patient’s medical circumstances.

But the phrase “may be eligible” is doing a great deal of work.

The program does not mean every Medicare beneficiary can obtain any GLP-1 medication for $50.

Eligibility can depend on:

• The specific medication
• The FDA-approved medical use
• The beneficiary’s diagnosis
• Whether the medication is participating in the program
• The person’s Part D coverage
• Program and plan requirements
• A valid prescription
• Any required medical documentation

Beneficiaries should not stop their current medication, change coverage, or assume they qualify based on an advertisement or headline.

They should speak with their physician and contact their Part D plan or the official program before making decisions.

The promise is significant. The fine print is equally significant.

Medicare Part B Costs Increased in 2026

CMS announced that the standard Medicare Part B monthly premium increased from $185 in 2025 to $202.90 in 2026.

That is an increase of $17.90 per month, or $214.80 over 12 months.

The annual Part B deductible also increased from $257 to $283.

People with higher incomes may pay more through the Income-Related Monthly Adjustment Amount, generally known as IRMAA.

These Part B costs apply whether a beneficiary receives care through Original Medicare or enrolls in a Medicare Advantage plan.

That last point is often misunderstood.

A Medicare Advantage plan may advertise a $0 plan premium, but the beneficiary normally must continue paying the Medicare Part B premium.

A $0 Medicare Advantage premium does not mean Medicare itself is free.

It means the private plan charges no additional monthly plan premium beyond the costs the beneficiary otherwise owes, although copayments, coinsurance, deductibles, drug expenses, and other charges may still apply.

Higher Government Payments Do Not Guarantee Better Benefits

For 2026, CMS estimated a 5.06% average increase—more than $25 billion—in Medicare Advantage plan payments.

For 2027, the projected increase is smaller at 2.48%, although it still represents more than $13 billion.

These figures frequently become political talking points. One side may call them generous increases. Another may argue they are insufficient when medical costs and utilization are rising.

Beneficiaries do not need to settle that argument.

What matters is what happens to their actual coverage.

Your plan could receive more federal funding and still change:

• Specialist copayments
• Hospital charges
• Dental benefits
• Over-the-counter allowances
• Prior-authorization requirements
• Provider networks
• Prescription tiers
• Pharmacy networks
• Maximum out-of-pocket limits

Do not confuse a payment announcement made to insurance companies with a benefit guarantee made to you.

They are not the same thing.

What Beneficiaries Should Do Now

Most 2027 plan-specific details will not be available until later in 2026.

Beneficiaries should watch for the Annual Notice of Change sent by their current plan before Medicare Open Enrollment.

Medicare Open Enrollment runs from October 15 through December 7 each year. Coverage changes made during that period generally begin January 1 of the following year.

When the 2027 plan information becomes available, review:

1. Your monthly premium
2. Your medical deductible
3. Your prescription deductible
4. Your doctors and hospitals
5. Your complete medication list
6. Your preferred pharmacies
7. Specialist and hospital copayments
8. Prior-authorization requirements
9. Dental, vision and hearing benefits
10. The medical maximum out-of-pocket limit

Even when you are satisfied with your current plan, compare it against the available alternatives.

Plans change.

Prescription formularies change.

Your health changes.

And sometimes the plan that was right for you three years ago is no longer the plan that fits your life today.

Our 2026 Medicare planning center explains how to compare total costs rather than focusing only on the monthly premium.

The Bottom Line

Recent CMS announcements point toward continued changes in Medicare Advantage payments, Part D drug coverage, plan-quality measurements, prescription payment options, and access to certain GLP-1 medications.

Some of these developments may help beneficiaries.

But no announcement eliminates the need to read the details.

A national rule does not tell you whether your cardiologist will remain in your plan.

A payment increase does not promise that your dental benefit will stay the same.

A $50 drug announcement does not mean every patient will qualify.

And a $0 plan premium does not mean $0 healthcare costs.

The smartest approach is not to panic every time CMS makes an announcement—and not to ignore the announcement either.

Review your coverage.

Check your medications.

Confirm your doctors.

Compare total annual costs.

And make your Medicare decision based on the plan that actually exists in your ZIP code, not the plan described in a television commercial.

MedicareSelfEnroll.com allows you to compare Medicare Advantage, Medicare Supplement and Part D options privately without pressure or an obligation to enroll.

Because the best Medicare decision is not necessarily the most heavily advertised one.

It is the one that fits your health, prescriptions, budget, and priorities.